Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Financial relationships between institutional review board members and industry.

Campbell EG, Weissman JS, Vogeli C, Clarridge BR, Abraham M, Marder JE, Koski G.

N Engl J Med. 2006 Nov 30;355(22):2321-9.

2.

Industry Relationships Among Academic Institutional Review Board Members: Changes From 2005 Through 2014.

Campbell EG, Vogeli C, Rao SR, Abraham M, Pierson R, Applebaum S.

JAMA Intern Med. 2015 Sep;175(9):1500-6. doi: 10.1001/jamainternmed.2015.3167.

PMID:
26168043
3.

Opinions of IRB Members and Chairs Regarding Investigators' Relationships with Industry.

Weissman JS, Koski G, Vogeli C, Thiessen C, Campbell EG.

J Empir Res Hum Res Ethics. 2008 Mar;3(1):3-13. doi: 10.1525/jer.2008.3.1.3.

PMID:
19385778
4.

Financial relationships of institutional review board members.

Miller FG.

N Engl J Med. 2007 Mar 1;356(9):965; author reply 965. No abstract available.

5.

Characteristics of medical school faculty members serving on institutional review boards: results of a national survey.

Campbell EG, Weissman JS, Clarridge B, Yucel R, Causino N, Blumenthal D.

Acad Med. 2003 Aug;78(8):831-6.

PMID:
12915379
6.

Patients' views on financial conflicts of interest in cancer research trials.

Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ.

N Engl J Med. 2006 Nov 30;355(22):2330-7.

7.

Policies and management of conflicts of interest within medical research institutional review boards: results of a national study.

Vogeli C, Koski G, Campbell EG.

Acad Med. 2009 Apr;84(4):488-94. doi: 10.1097/ACM.0b013e31819a8ae7.

8.

"Members of the same club": challenges and decisions faced by US IRBs in identifying and managing conflicts of interest.

Klitzman R.

PLoS One. 2011;6(7):e22796. doi: 10.1371/journal.pone.0022796. Epub 2011 Jul 29.

9.

"Conflict-of-interest" and participation in IRB deliberations: an alternative perspective.

Markman M.

Cancer Invest. 2008 Mar;26(2):115-7. doi: 10.1080/07357900701579562. Review.

PMID:
18259940
10.
11.

Conflict-of-interest policies for investigators in clinical trials.

Lo B, Wolf LE, Berkeley A.

N Engl J Med. 2000 Nov 30;343(22):1616-20.

12.

Conflicts of interest in research involving human beings.

Greco D, Diniz NM.

J Int Bioethique. 2008 Mar-Jun;19(1-2):143-54, 202-3. Review.

PMID:
18664007
13.

A national survey of policies on disclosure of conflicts of interest in biomedical research.

McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP, Brody BA.

N Engl J Med. 2000 Nov 30;343(22):1621-6.

14.

Assessing faculty financial relationships with industry: A case study.

Boyd EA, Bero LA.

JAMA. 2000 Nov 1;284(17):2209-14.

PMID:
11056592
15.

Responses of medical schools to institutional conflicts of interest.

Ehringhaus SH, Weissman JS, Sears JL, Goold SD, Feibelmann S, Campbell EG.

JAMA. 2008 Feb 13;299(6):665-71. doi: 10.1001/jama.299.6.665.

PMID:
18270355
16.

Relationships between academic institutions and industry in the life sciences--an industry survey.

Blumenthal D, Causino N, Campbell E, Louis KS.

N Engl J Med. 1996 Feb 8;334(6):368-73.

17.

The limits of disclosure: what research subjects want to know about investigator financial interests.

Grady C, Horstmann E, Sussman JS, Hull SC.

J Law Med Ethics. 2006 Fall;34(3):592-9, 481.

PMID:
17144183
18.

Potential research participants' views regarding researcher and institutional financial conflicts of interest.

Kim SY, Millard RW, Nisbet P, Cox C, Caine ED.

J Med Ethics. 2004 Feb;30(1):73-9.

19.
20.

Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators.

Weinfurt KP, Friedman JY, Dinan MA, Allsbrook JS, Hall MA, Dhillon JK, Sugarman J.

J Law Med Ethics. 2006 Fall;34(3):581-91, 481.

Items per page

Supplemental Content

Write to the Help Desk